SCHEMBL27991640

SCHEMBL27991640

Cc1cc(Nc2ccc(F)cc2)ncn1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.60
CYP2C19 P33261 4/20 0.60
MAPK1 P28482 4/20 0.60
CYP3A4 P08684 3/20 0.60
CYP2D6 P10635 3/20 0.60
HPGD P15428 1/20 0.60
CD274 Q9NZQ7 1/20 0.59
THRB P10828 1/20 0.55
MEN1 O00255 5/20 0.55
KMT2A Q03164 5/20 0.55
USP2 O75604 2/20 0.55
ALDH1A1 P00352 2/20 0.55
ALOX15 P16050 2/20 0.55
HSD17B10 Q99714 2/20 0.55
CLK4 Q9HAZ1 2/20 0.55
TP53 P04637 1/20 0.55
GLA P06280 1/20 0.55
CYP2C9 P11712 1/20 0.55
MAPK10 P53779 2/20 0.54
EGFR P00533 4/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL373960 0.82 EGFR (0.57) CYP1A2CYP2C19MAPK1CYP3A4CYP2D6
SCHEMBL374096 0.80 CDK5 (0.61) CYP1A2CYP2C19MAPK1CYP3A4CYP2D6
SCHEMBL22328022 0.79 NPC1 (0.64) CYP1A2CYP2C19MAPK1CYP3A4CYP2D6
SCHEMBL11919063 0.77 CD274 (0.54) CYP1A2CYP2C19MAPK1CYP3A4CYP2D6
SCHEMBL14818976 0.75 KDM4E (0.50) CYP1A2CYP2C19MAPK1CYP2D6HPGD
SCHEMBL21645363 0.73 KMO (0.65) CYP1A2CYP2C19MAPK1CYP3A4CYP2D6
SCHEMBL27317919 0.73 EGFR (0.49) CYP1A2CYP2C19MAPK1CYP3A4CYP2D6
SCHEMBL3225967 0.73 EGFR (0.57) CYP1A2CYP2C19MAPK1CYP3A4CYP2D6
SCHEMBL18153382 0.72 POLB (0.57) CYP1A2CYP2C19MAPK1CYP3A4CYP2D6
SCHEMBL13963083 0.72 RAB9A (0.71) CYP1A2CYP2C19MAPK1CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104203939-A Diaminopyrimidines as human Respiratory Syncytial Virus (RSV) inhibitors ABBVIE INC 2014-12-10 CN disclosed